Abbott Laboratories Statistics

Total Valuation

FRA:ABL has a market cap or net worth of EUR 206.52 billion. The enterprise value is 212.54 billion.

Market Cap	206.52B
Enterprise Value	212.54B

Important Dates

The next estimated earnings date is Wednesday, July 16, 2025.

Earnings Date	Jul 16, 2025
Ex-Dividend Date	Apr 15, 2025

Share Statistics

Current Share Class	1.74B
Shares Outstanding	n/a
Shares Change (YoY)	-0.06%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.73B

Valuation Ratios

The trailing PE ratio is 16.59 and the forward PE ratio is 24.84.

PE Ratio	16.59
Forward PE	24.84
PS Ratio	5.27
PB Ratio	4.55
P/TBV Ratio	11.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.76, with an EV/FCF ratio of 34.51.

EV / Earnings	17.08
EV / Sales	5.58
EV / EBITDA	20.76
EV / EBIT	30.10
EV / FCF	34.51

Financial Position

The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.27.

Current Ratio	1.78
Quick Ratio	1.09
Debt / Equity	0.27
Debt / EBITDA	1.17
Debt / FCF	2.00
Interest Coverage	14.30

Financial Efficiency

Return on equity (ROE) is 30.65% and return on invested capital (ROIC) is 8.45%.

Return on Equity (ROE)	30.65%
Return on Assets (ROA)	6.38%
Return on Invested Capital (ROIC)	8.45%
Return on Capital Employed (ROCE)	11.47%
Revenue Per Employee	343,655
Profits Per Employee	109,165
Employee Count	114,000
Asset Turnover	0.55
Inventory Turnover	2.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +21.70% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+21.70%
50-Day Moving Average	118.22
200-Day Moving Average	111.39
Relative Strength Index (RSI)	53.05
Average Volume (20 Days)	337

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.97

Income Statement

In the last 12 months, FRA:ABL had revenue of EUR 39.18 billion and earned 12.44 billion in profits. Earnings per share was 7.13.

Revenue	39.18B
Gross Profit	21.93B
Operating Income	7.26B
Pretax Income	6.80B
Net Income	12.44B
EBITDA	10.20B
EBIT	7.26B
Earnings Per Share (EPS)	7.13

Full Income Statement

Balance Sheet

The company has 6.33 billion in cash and 12.30 billion in debt, giving a net cash position of -5.96 billion.

Cash & Cash Equivalents	6.33B
Total Debt	12.30B
Net Cash	-5.96B
Net Cash Per Share	n/a
Equity (Book Value)	45.39B
Book Value Per Share	25.96
Working Capital	9.39B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.28 billion and capital expenditures -2.12 billion, giving a free cash flow of 6.16 billion.

Operating Cash Flow	8.28B
Capital Expenditures	-2.12B
Free Cash Flow	6.16B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 55.99%, with operating and profit margins of 18.54% and 31.89%.

Gross Margin	55.99%
Operating Margin	18.54%
Pretax Margin	17.37%
Profit Margin	31.89%
EBITDA Margin	26.03%
EBIT Margin	18.54%
FCF Margin	15.72%

Dividends & Yields

This stock pays an annual dividend of 2.10, which amounts to a dividend yield of 1.78%.

Dividend Per Share	2.10
Dividend Yield	1.78%
Dividend Growth (YoY)	7.50%
Years of Dividend Growth	6
Payout Ratio	28.92%
Buyback Yield	0.06%
Shareholder Yield	1.83%
Earnings Yield	6.03%
FCF Yield	2.98%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:ABL has an Altman Z-Score of 5.49.

Altman Z-Score	5.49
Piotroski F-Score	n/a